Access Statistics for Christopher James Sampson

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A Framework for Value-aligned Pricing of Combination Therapies 0 0 2 6 1 1 8 17
Barriers to Uptake of Minimal Access Surgery in the United Kingdom 0 0 0 2 1 2 14 24
Cost implications of treatment non-completion in a forensic personality disorder service 0 0 0 15 0 0 17 60
Drop Dead: Is Anchoring at ‘Dead’ a Theoretical Requirement in Health State Valuation? 0 0 0 9 1 1 12 40
Happy and healthy: a joint model of health and life satisfaction 0 0 0 87 1 1 15 302
How Should We Measure Quality of Life Impact in Rare Disease? Recent Learnings in Spinal Muscular Atrophy 0 0 1 29 0 0 18 108
How is Quality of Life Measured for Health Technology Assessments? 1 1 2 17 1 1 22 62
R&D, Competition and Diffusion of Innovation in the EU: The Case of Hepatitis C 0 0 0 1 0 0 10 15
The Case for Expanding Uptake of Next-Generation Sequencing for Lung Cancer in Europe 0 0 2 7 0 0 12 25
The Impact of New Medicines in the NHS: 70 Years of Innovation 0 0 0 1 0 0 5 12
The impact of inflation on incremental costs in HTA 0 9 9 9 2 17 17 17
The relationship between individual risk and cost-effectiveness in screening interventions 0 0 0 43 1 2 11 303
The value of cell and gene therapies to the UK economy 1 1 1 1 2 5 5 5
Total Working Papers 2 11 17 227 10 30 166 990
4 registered items for which data could not be found


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Do patients registered with CAM-trained GPs really use fewer health care resources and live longer? A response to Kooreman and Baars. Eur J Health Econ (2012). 13:469–776 0 0 0 3 1 1 17 97
Health Opportunity Costs and Expert Elicitation: A Comment on Soares et al 0 0 0 1 0 1 9 16
Is anchoring at ‘dead’ a theoretical requirement for health state valuation? 0 0 0 1 0 1 13 19
Marginal cost per QALY estimates: What are they good for? 0 0 2 11 0 1 25 62
Model Registration: A Call to Action 0 0 0 4 0 1 9 70
NICE and the EQ-5D-5L: Ten Years Trouble 0 0 1 4 0 1 8 26
Supply-Side Cost-Effectiveness Thresholds: Questions for Evidence-Based Policy 0 1 18 29 0 2 76 152
Transparency in Decision Modelling: What, Why, Who and How? 0 0 0 4 0 1 16 68
Total Journal Articles 0 1 21 57 1 9 173 510


Statistics updated 2026-09-10